International Finance
Featured Healthcare

uMore becomes first UAE startup to join TheVentureCity accelerator

uMore UAE_IFM_Image
The healthtech has raised around $120,000

Healthtech startup uMore became the first UAE-based startup to be accepted to join TheVentureCity, media reports said. The product-led growth programme is an international venture acceleration programme built by Laura González-Estéfani, Facebook’s former head of growth, mobile and partnerships for Latin America. The startup has also raised around $120,000.

Maria de Freitas, co-founder and chief executive officer at uMore told the media, “We are very excited about the opportunity that TheVentureCity gives us, not only to validate our work but also to scale at super-sonic speed.”

“What we’re most looking forward to is that the program has a product-led growth approach, and that’s strongly aligned with our values. At uMore, we learn by continuously iterating, which allows us to test our hypotheses in real-time. We invest in experiences to drive growth, and we prioritise impact over effort. We believe that together with TheVentureCity’s global community of best-in-class, technology-focused mentors, the sky is the limit.”

Launched in December 2020, uMore is a digital health screening and recommendation platform. It uses machine learning and digital phenotyping to provide accessible and personalised mental health care to its users. The platform has around 3,000 users and is one of the UAE’s Top 50 apps under Health and Fitness.

Last year, the UAE’s Ministry of Health and Prevention launched an AI-backed healthcare app during the Arab Health 2020 event, which was held at the Dubai World Trade Centre.

The UAE smart healthcare app facilitates communication between deaf and mute patients and medical practitioners. The UAE healthcare app is designed to help doctors and medical providers better understand the health conditions of such patients.

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.